Mapmygenome India announced the start of operations in Delhi-NCR beginning June 1, 2015 and an expanded team including changes in top management. This is their first team expansion following a Pre Series A round of USD 1.1 million funding in March 2015.
The strategic move to start operations in Delhi-NCR aims to close the gap by fulfilling an existing need for genomic testing and genetic counselling services in North India. The Delhi team will focus on more personalized and efficient genomics services there. Access to North India markets will also help in targeted efforts for raising awareness about genomics testing.
The new team in Delhi comprises Chief Medical Officer - Dr. Naveen Talwar, VP Business Development - Dr. Jaishree Srinivasan, senior genetic counselors, admin, and sales personnel. Additions to Hyderabad team include Sr. VP Operations - Wing Commander (Dr.) M.K. Bose and marketing team.
Ms. Anu Acharya, CEO of Mapmygenome, said, "A new office in Delhi-NCR is a key strategic move for us. With two offices and an expanded team, we are sure to see an exponential increase in sales and performance."
BusinessWire India.com - Healthcare & biotechnology
Business Wire India 1.7 million new stroke cases occur every year in India. Stroke affects young people
Business Wire IndiaOn the eve of World Obesity Day Global Obesity Support Group a decade old initiative
Business Wire IndiaMs. Sangita Reddy, Joint Managing Director - Apollo Hospitals Enterprises Limited,
BusinessWire India.com - Medical Devices
Business Wire India Q2 Solutions, a global clinical trials laboratory services organization, today announced